March 13, 2015
Eisai said on March 12 that it has revised its collaboration pact with US biotech Epizyme Inc. for the development and commercialization of cancer therapeutics targeting EZH2, an epigenetic enzyme. The Japanese drug maker is currently carrying out a PI/II...read more